Ming Xu
Vice President - Oncology & Product Team Lead Bayer
Seminars
Thursday 3rd December 2026
Developing Robust Drug Product Strategies to Enable Successful Radiopharmaceutical Development
12:00 pm
- Defining drug product strategies that support progression from early development through commercialisation
- Balancing formulation, manufacturability and product quality to enable reliable clinical supply
- Integrating CMC, regulatory and clinical considerations into drug product development plans
- Lessons learned overcoming key challenges in developing scalable radiopharmaceutical drug products
